Pathologic Stage II Esophageal Adenocarcinoma AJCC v8: Clinical Trials

6 trials for Pathologic Stage II Esophageal Adenocarcinoma AJCC v8, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting, 1 recruiting. 2 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Recruiting 1
Not applicable1Completed 1
Phase 21Active not recruiting 1

Follow Pathologic Stage II Esophageal Adenocarcinoma AJCC v8: new trials by email Literature Review of Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 trials Research Report on Pathologic Stage II Esophageal Adenocarcinoma AJCC v8

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
Carboplatin, Paclitaxel, Radiation Therapy - Advanced Esophageal Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma
Phase 1Active not recruitingNRG Oncology162021-12-022026-10-01
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
Capecitabine, Carboplatin, Docetaxel - Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8
Phase 1RecruitingM.D. Anderson Cancer Center242020-11-232026-10-07
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Patient Monitoring, Questionnaire Administration - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
CompletedCity of Hope Medical Center222020-08-112026-10-14
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study
Patient Monitoring System, Questionnaire Administration, Consultation - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
Not applicableCompletedThomas Jefferson University342020-04-152025-05-15
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Biospecimen Collection, Cardiac Event Monitor, Chemoradiotherapy - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8
CompletedMayo Clinic242019-09-232026-05-27
Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma
Atezolizumab, Conventional Surgery, Fluorouracil - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2Active not recruitingM.D. Anderson Cancer Center432019-02-192026-07-28

Narrower conditions

Colorectal Neoplasms (2)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Gastrointestinal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms, Squamous Cell (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)  ·  Urogenital Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Carcinoma (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Rectal Diseases (2)  ·  Adenocarcinoma (1)

Interventions

Carboplatin (2)  ·  Fluorouracil (2)  ·  Oxaliplatin (2)  ·  Paclitaxel (2)  ·  Radiation (2)  ·  Radiotherapy (2)  ·  Taxes (2)  ·  dehydroftorafur (2)  ·  Capecitabine (1)  ·  Chemoradiotherapy (1)  ·  Docetaxel (1)  ·  Leucovorin (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Referral and Consultation (1)  ·  Remote Patient Monitoring (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  City of Hope Medical Center (1)  ·  Mayo Clinic (1)  ·  NRG Oncology (1)  ·  Thomas Jefferson University (1)

Countries

United States (6)

Top investigators

Carlos E. Vargas, M.D. (1)  ·  Geoffrey Y Ku (1)  ·  Kuang-Yi Wen, MD (1)  ·  Laleh Melstrom (1)  ·  Mariela Blum (1)  ·  Steven H Lin (1)

NIH funding

P30CA033572 (1), U10CA180868 (1)